Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Guelph
$105,000.00
Investigating the role of oral bacterium Fusobacterium nucleatum in human colorectal cancer
FY 2019-20
Summary
In Canada, colorectal cancer (CRC) is among the commonly diagnosed cancers, and a leading cause of cancer-associated death. Fusobacterium nucleatum (Fn) is a pathogenic bacterium linked to CRC, but its exact pathogenesis remains elusive. Fn is commonly found in the human mouth, but it has been detected in various other body sites in cases of disease, such as in CRC. Colonic presence of Fn is associated with poorer cancer survival rates. Unfortunately, not all Fn strains are virulent, which prevents using Fn presence as a diagnostic tool. Colonic Fn infections may result from the bacterium-known to breach and invade human cells-crossing layers of human tissue to reach the bloodstream. Although there have been several studies of this infection route and CRC development in mouse models, the relevance to human disease is not clear. We have analyzed how an invasive strain of Fn, strain 7/1, adapts by changing its gene expression as it invades a human cancerous colonic cell line, Caco-2, as well as the Caco-2 cell's response to invasion by Fn 7/1. The goal of this research is to extend the previous work using CRC-derived Fn strains, and noncancerous gingival, vascular and colonic cells derived from both human and mouse sources. This is important because it will a) indicate relevance of the mouse model to human Fn infection; and b) detect host and pathogen genes consistently expressed during infection, which will become future targets for interventions and potentially biomarkers for CRC risk and/or complications. Future goals for this project include analyzing the role of Fn in multi-bacterial infection of human colonic cells. Additionally, the potential interactions between Fn and other cancer-promoting bacteria and a healthy gut microbial community will be examined using a bioreactor model of the human colon.
This research is supported through an Innovation to Impact grant from the Canadian Cancer Society, and the Grant Challenge initiative through Cancer Research UK.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
417213
Name
Robinson Avery
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating the role of oral bacterium Fusobacterium nucleatum in human colorectal cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Cancer Biomarkers; Colonic Microbiome; Colorectal Cancer; Fusobacterium Nucleatum; Host-Pathogen Interactions; Metabolomics; Polymicrobial Infection; Transcriptomics
Abstract
In Canada, colorectal cancer (CRC) is among the commonly diagnosed cancers, and a leading cause of cancer-associated death. Fusobacterium nucleatum (Fn) is a pathogenic bacterium linked to CRC, but its exact pathogenesis remains elusive. Fn is commonly found in the human mouth, but it has been detected in various other body sites in cases of disease, such as in CRC. Colonic presence of Fn is associated with poorer cancer survival rates. Unfortunately, not all Fn strains are virulent, which prevents using Fn presence as a diagnostic tool. Colonic Fn infections may result from the bacterium-known to breach and invade human cells-crossing layers of human tissue to reach the bloodstream. Although there have been several studies of this infection route and CRC development in mouse models, the relevance to human disease is not clear. We have analyzed how an invasive strain of Fn, strain 7/1, adapts by changing its gene expression as it invades a human cancerous colonic cell line, Caco-2, as well as the Caco-2 cell's response to invasion by Fn 7/1. The goal of this research is to extend the previous work using CRC-derived Fn strains, and noncancerous gingival, vascular and colonic cells derived from both human and mouse sources. This is important because it will a) indicate relevance of the mouse model to human Fn infection; and b) detect host and pathogen genes consistently expressed during infection, which will become future targets for interventions and potentially biomarkers for CRC risk and/or complications. Future goals for this project include analyzing the role of Fn in multi-bacterial infection of human colonic cells. Additionally, the potential interactions between Fn and other cancer-promoting bacteria and a healthy gut microbial community will be examined using a bioreactor model of the human colon.
This research is supported through an Innovation to Impact grant from the Canadian Cancer Society, and the Grant Challenge initiative through Cancer Research UK.
Competitiondate
201911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Robinson, Avery
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~